Home
Conditions
Optic Nerve Glioma

Clinical trial condition

Optic Nerve Glioma

Explore clinical trials studying Optic Nerve Glioma. Study availability and eligibility vary by location and protocol.

63 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Optic Nerve Glioma trial results

Recruiting

Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

NCT04648462

Conditions: Adenoma, Astrocytoma, Central Nervous System Neoplasms, +33 more
Locations: Maastricht Radiation Oncology Maastricht, Limburg, Netherlands

Holland PTC Delft, South Holland, Netherlands

Universitair Medisch Centrum Groningen Groningen, Netherlands

View Trial Details

Recruiting

Modified CV Regimen in Optic Pathway Glioma

NCT05278715

Conditions: Cranial Nerve Diseases, Cranial Nerve Neoplasms, Eye Diseases, +17 more
Locations: Capital Medical University Sanbo Brain Hospital Beijing, China

View Trial Details

Completed

Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor

NCT00638898

Conditions: Adult Central Nervous System Germ Cell Tumor, Adult Rhabdomyosarcoma, Astrocytoma, +86 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

NCT01553149

Conditions: Astrocytoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +31 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

View all 126 locations

View Trial Details

Completed

A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas

NCT01837862

Conditions: Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +34 more
Locations: Cohen Children's Medical Center of New York New Hyde Park, New York, United States

View Trial Details

Completed

Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

NCT03326388

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations: Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom

Great Ormond Street Hospital NHS Foundatin Trust London, United Kingdom

View Trial Details

Completed

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

NCT00445965

Conditions: Adnexal Diseases, Astrocytoma, Brain Diseases, +88 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

NCT00019630

Conditions: Adenocarcinoma, Astrocytoma, Bone Cancer, +85 more
Locations: Pediatric Oncology Branch Bethesda, Maryland, United States

Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma

NCT02839720

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +29 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid Tumors

NCT00138216

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +30 more
Locations: Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States

Children's Hospital of Orange County Orange, California, United States

Stanford Cancer Center Stanford, California, United States

Children's Memorial Hospital - Chicago Chicago, Illinois, United States

View all 18 locations

View Trial Details

Optic Nerve Glioma

Optic Nerve Glioma trial results

Related conditions